UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low‐dose‐rate brachytherapy for prostate cancer: A 15‐year experience in Japan

International journal of urology, 2020-01, Vol.27 (1), p.17-23

2020

Volltextzugriff (PDF)

Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer

Scientific reports, 2022-06, Vol.12 (1), p.11023-11023, Article 11023

2022

Volltextzugriff (PDF)

Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low‐dose‐rate brachytherapy

International journal of urology, 2022-12, Vol.29 (12), p.1560-1568

2022

Volltextzugriff (PDF)

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer

BMC cancer, 2017-08, Vol.17 (1), p.573-573, Article 573

2017

Volltextzugriff (PDF)

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer

Radiation oncology (London, England), 2022-04, Vol.17 (1), p.71-71, Article 71

2022

Volltextzugriff (PDF)

Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low‐dose‐rate brachytherapy: A randomized controlled study

International journal of urology, 2020-11, Vol.27 (11), p.1013-1017

2020

Volltextzugriff (PDF)

Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil

International journal of urology, 2021-11, Vol.28 (11), p.1171-1176

2021

Volltextzugriff (PDF)

Income and Employment of Patients at the Start of and During Follow-up After Palliative Radiation Therapy for Bone Metastasis

Advances in radiation oncology, 2023-07, Vol.8 (4), p.101205-101205, Article 101205

2023

Volltextzugriff (PDF)

Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial

International journal of urology, 2020-09, Vol.27 (9), p.755-759

2020

Volltextzugriff (PDF)

Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone

Japanese journal of clinical oncology, 2020-01, Vol.50 (1), p.58-65

2020

Volltextzugriff (PDF)

Urethral toxicity after LDR brachytherapy: Experience in Japan

Brachytherapy, 2015-03, Vol.14 (2), p.131-135

2015

Volltextzugriff (PDF)

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy

Radiation oncology (London, England), 2013-01, Vol.8 (1), p.25-25, Article 25

2013

Volltextzugriff (PDF)

The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions

Radiation oncology (London, England), 2014-05, Vol.9 (1), p.107-107, Article 107

2014

Volltextzugriff (PDF)

Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer

Radiotherapy and oncology, 2015-06, Vol.115 (3), p.321-326

2015

Volltextzugriff (PDF)

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute

BMC urology, 2017-08, Vol.17 (1), p.62-62, Article 62

2017

Volltextzugriff (PDF)

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil

Radiation oncology (London, England), 2014-12, Vol.9 (1), p.302-302, Article 302

2014

Volltextzugriff (PDF)

Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy

Journal of Gynecologic Oncology, 2013, 24(4), , pp.313-320

2013

Volltextzugriff (PDF)

Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer

Journal of radiation research, 2019-03, Vol.60 (2), p.270-280

2019

Volltextzugriff (PDF)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer

Clinical and translational radiation oncology, 2019-01, Vol.14, p.51-58

2019

Volltextzugriff (PDF)

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions

Prostate international, 2019-06, Vol.7 (2), p.47-53

2019

Volltextzugriff (PDF)

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

Journal of contemporary brachytherapy, 2019-01, Vol.11 (5), p.409-416

2019

Volltextzugriff (PDF)

Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer

Journal of radiation research, 2013-07, Vol.54 (4), p.671-678

2013

Volltextzugriff (PDF)

A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study

Contemporary clinical trials communications, 2020-09, Vol.19, p.100593, Article 100593

2020

Volltextzugriff (PDF)

Phantom Study on Radiotherapy Planning Using PET/CT -Delineation of GTV by Evaluating SUV

JOURNAL OF RADIATION RESEARCH, 2010, Vol.51 (2), p.157-164

2010

Volltextzugriff (PDF)

Localized prostate cancer with pelvic arteriovenous malformation treated with low‐dose‐rate brachytherapy after transcatheter embolization: Two case reports

IJU case reports, 2019-03, Vol.2 (2), p.90-94

2019

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(71)
Humans
(47)
Male
(39)
Prostate Cancer
(38)
Brachytherapy
(28)
Oncology
(27)
Prostatic Neoplasms - Radiotherapy
(26)
Radiation Therapy
(24)
Aged
(23)
Middle Aged
(21)
Radiology, Nuclear Medicine & Medical Imaging
(20)
Biological And Medical Sciences
(16)
Urology & Nephrology
(15)
Care And Treatment
(14)
Quality Of Life
(14)
Radiotherapy
(14)
Brachytherapy - Adverse Effects
(13)
Radiotherapy Dosage
(13)
Animals
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Low‐dose‐rate brachytherapy for prostate cancer: A 15‐year experience in Japan

Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer

Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low‐dose‐rate brachytherapy

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer

Coverage of the external prostatic region by the hybrid method compared with the conventional method of prostate low‐dose‐rate brachytherapy: A randomized controlled study

Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil

Income and Employment of Patients at the Start of and During Follow-up After Palliative Radiation Therapy for Bone Metastasis

Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial

Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone

Urethral toxicity after LDR brachytherapy: Experience in Japan

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy

The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions

Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil

Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy

Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer

A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study

Phantom Study on Radiotherapy Planning Using PET/CT -Delineation of GTV by Evaluating SUV

Localized prostate cancer with pelvic arteriovenous malformation treated with low‐dose‐rate brachytherapy after transcatheter embolization: Two case reports

Suchergebnisse filtern